tirzepatide to ozempic conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are What is the recommended conversion

The CMA count and the timing gap The CMA's consumer-facing explainer states that, as of late December 2025, Health Canada had nine active applications from companies that want to sell generic semaglutide

Over 41 days, daily doses of cotadutide of up to 200 g led to improved glucose AUC 0-4h after a mixed meal in comparison to placebo as well as fasting and post prandial glucose levels

Functional medicine can save lives through effective collaborations within health organizations

While most people will experience appetite suppression within a week of starting Zepbound, factors such as dosage, metabolism, and diet can all impact the effectiveness of the treatment